Cerity Partners LLC Haemonetics Corp Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Cerity Partners LLC holds 11,058 shares of HAE stock, worth $691,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,058
Previous 8,345
32.51%
Holding current value
$691,014
Previous $651,000
7.83%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
342Shares Held
51.2MCall Options Held
586KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$372 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$319 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$276 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$265 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$160 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.21B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...